Atlas Trials

Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy

Clinical trial NCT01343121 · COMPLETED

Trial details

NCT number
NCT01343121
Sponsor
The Christie NHS Foundation Trust
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2012-02-02
Primary completion
2017-11-24
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.